Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Lung Neoplasms × capmatinib × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 6 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma of Lung 1

Interventions

trilaciclib 1 taletrectinib 1 lazertinib 1 dabrafenib 1 capmatinib 1 brigatinib 1 Suspensions 1 Powders 1 Paclitaxel 1 BID protein, human 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04741789 2026-03-16

Managed Access Programs for INC280, Capmatinib

Novartis

No longer available

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡